Compound Detail
CHEMBL1200976
IDARUBICIN HYDROCHLORIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O.Cl
Basic Information
| ChEMBL ID | CHEMBL1200976 |
| Name | IDARUBICIN HYDROCHLORIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | JVHPTYWUBOQMBP-RVFAQHLVSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1117 |
| Active Moiety | CHEMBL1117 |
8
Targets
19
Activities
2
Assay Types
0
PK Parameters
18
Publications
9
Known Names
3
Indications
2
Mechanisms
Molecular Properties
497.5
MW (Da)
1.02
ALogP
10
HBA
5
HBD
176.6
PSA (Ų)
0.33
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1990 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| DNA topoisomerase II alpha inhibitor | INHIBITOR | DNA topoisomerase 2-alpha | ✓ | ✓ |
| DNA inhibitor | INHIBITOR | DNA | ✓ | ✓ |
Indications
Leukemia, Myeloid, Acute Carcinoma, Hepatocellular Leukemia, Myeloid
Drug Warnings
Black Box Warning
hematological toxicity
Black Box Warning
cardiotoxicity
Activity Summary
IC50 11 meas. best 7.96
EC50 8 meas. best 6.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.96 | 6.6344 | 11.1 | 9 |
| Unchecked CHEMBL612545 | EC50 | 6.75 | 6.495 | 178.0 | 2 |
| BJ CHEMBL614358 | EC50 | 6.55 | 6.49 | 280.0 | 2 |
| MUS81-ECE1 CHEMBL5465380 | IC50 | 6.21 | 6.21 | 610.0 | 1 |
| Streptococcus sp. 'group A' CHEMBL612389 | EC50 | 5.97 | 5.97 | 1075.0 | 1 |
| Streptokinase A CHEMBL1293228 | EC50 | 5.95 | 5.95 | 1129.0 | 1 |
| Streptococcus CHEMBL612313 | EC50 | 5.58 | 5.58 | 2605.0 | 1 |
| Heat shock factor protein 1 CHEMBL5313 | EC50 | 5.52 | 5.52 | 3007.0 | 1 |
| Jurkat CHEMBL397 | IC50 | 5.47 | 5.47 | 3350.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495565 | Vero C1008 | 2 |
| - | 10.6019/CHEMBL4495565 | ADMET | 2 |
| - | 10.6019/CHEMBL4513141 | Escherichia coli | 1 |
| 37352577 | 10.1016/j.bmc.2023.117383 | MUS81-ECE1 | 1 |
| - | 10.6019/EOS300108 | HepG2 | 1 |
| - | 10.6019/EOS300033 | SARS-CoV-2 | 1 |
| - | 10.6019/CHEMBL4513141 | HEK293 | 1 |
| - | 10.6019/CHEMBL4513141 | Staphylococcus aureus | 1 |
| - | 10.6019/CHEMBL4513141 | Acinetobacter baumannii | 1 |
| - | 10.6019/CHEMBL4513141 | Pseudomonas aeruginosa | 1 |
| - | 10.6019/CHEMBL4513141 | Klebsiella pneumoniae | 1 |
| 20553011 | 10.1021/tx1000865 | Hepatotoxicity | 1 |
| - | 10.6019/CHEMBL4513141 | Cryptococcus neoformans | 1 |
| - | 10.6019/CHEMBL4513141 | Candida albicans | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 20843939 | 10.1124/dmd.110.035113 | Hepatotoxicity | 1 |
Data from ChEMBL 36 via Core Engine